Targeted Therapy Leads 2012 Cancer Advances

(MedPage Today) — Targeted therapies for metastatic HER2-positive breast cancer are among this year’s top advances in oncology, according to the American Society of Clinical Oncology.

Post a Comment

Comments are closed.